How the FMR1 gene became relevant to female fertility and reproductive medicine

Frontiers in Genetics

Volumn 5, Issue AUG, 2014, Pages

  Gleicher, Norbert ^a,b   Kushnir, Vitaly A ^a   Weghofer, Andrea ^a,c   Barad, David H ^a,b  

^a Center for Human Reproduction New York   (United States)

^b Foundation for Reproductive Medicine   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; MUELLERIAN INHIBITING FACTOR;

ALLELE; ARTICLE; CRYOPRESERVATION; FEMALE FERTILITY; FERTILIZATION IN VITRO; FMR1 GENE; GENE; GENE EXPRESSION; GENOTYPE; HUMAN; NONHUMAN; OVARIAN RESERVE; OVARY FOLLICLE; PREMATURE OVARIAN FAILURE; PROTEIN EXPRESSION; REPRODUCTION; TRINUCLEOTIDE REPEAT;

EID: 84906223689     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00284     Document Type: Article

References (33)

1. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456-465
2. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlataion of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril 2009;91:1700-1706.
3. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril 2009;91:1707-1711
4. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG, Jr., Warren ST, et al. Variations in CGG repeat of the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-1058
5. Chen LS, Tassone F, Sahota P, Hagerman PJ. The (CGG)n repeat element within the 5' untranslated region of the fMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum Mol Genet 2003;12:3067-3074
6. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing. Reprod Biomed Online 2010;20:768-775
7. Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunityassociated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS ONE 2010;5(12):e15303.
8. Gleicher N, Weghofer A, Oktay K, Barad DH. Can the FMR1 (fragile X) gene serve as a predictor of response to ovarian stimulation? Reprod Sci 2009;16:462-467
9. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X0 gene to ovarian reserve: a new infertility test? Acta Obstet Gynecol Scand 2009;88:1024-1030
10. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009;19:385-390
11. Gleicher N, Barad DH. Can the FMR1 gene predict early aging? Women's Health (London, Eng) 2010;6:165-169
12. Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012;7(3):e33638
13. Gleicher N, Weghofer A, Kim A, Barad DH. Comparison of ovarian FMR1 genotypes and sub-genotypes in oocyte donors and infertile women. J Assist Reprod Genet 2012;29:529-532
14. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Reprod Biomed Online 2010;20:48-491
15. Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol 2012;10:77
16. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race. PLoS ONE 2011;6(4):e18781
17. Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee H-J, Wu Y-G, Shohat-Tal A, Lazzaroni-Tealdi E, Gleicher N. Utilizing FMR1 mutations as predictors of treatment success in human in vitro fertilization. PLoS ONE 2014; in press;
18. Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee H.J., Kushnir VA, Weghofer A. FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors. Reprod Biol Endocrinol 2013;11(1):80
19. Gleicher N, Weghofer A, Barad DH. Can egg donor selection be improved? - A pilot study. Reprod Biol Endocrinol 2010;8;76
20. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod 2012;27:3287-3293
21. Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod 2013;28:1084-1091
22. Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet 2013;30:49-62
23. Lu C, Lin L, Tan H, Wu H, Sherman SL, Gao F, Jin P, Chen D. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Molec Genet 2012;21:5039-5047
24. Hooman GE, Le WW, Entezam A, Otsuka N, Tong ZB, Nelson L, Flaws JA, McDonald JH, Jafar S, Usdin K. Ovarian abnormalities in mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem 2012;60:439-456
25. Ascano Jr. M, Mukjerjee N, Bandaru P, Miller JB, Nusbaum J, Corcoran DL, Langlois C, Munschauer M, Dewell S, Hafner M, Williams Z, Ohler U, Tuschi T. FMR1 targets distinct mRNA sequence element to regulate protein expression. Nature 2012;492:382-386
26. Ferder I, Parborell F, Sundblad V, Chiauzzi V, Gómez K, Charreau EH, Tesone M, Dain L. Expression of fragile X mental retardation protein and Fmr1 mRNA during folliculogenesis in the rat. Reproduction 2013;145:335-343
27. Schuettler J, Peng Z, Zimmer J, Sinn P, von Hagens C, Strwitzki T, Vogt PH. Variable expression of the Fragile X Mental Retardation 1 (FMR1) gene in patients with premature ovarian failure syndrome is not dependent on number of (CGG)n triples in exon 1. Hum Reprod 2011;26:1241-1251
28. Pastore LM, Young SL, Baker VL, Karns LB, Williams CD, Silverman LM. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci 2012;19:1226-1231
29. Barasoain M, Barrenetxea G, Huerta I, Télez M, Cérez C, Criado B, Arrieta I. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country. Gene 2013;521:145-149
30. De Geyter C, M'rabel N, de Geyter J, Zürcher S, Moffat R, Bösch N, Zhang H, Heinimann K. Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation 1 gene among infertile women and among women with proven fertility: a prospective study. Genet med 2014;16:374-378 30 Voorhuis M, Onland-Moret NC, Fauser BC, Ploos van Amstel HK, van der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod 2013;28:496-501
31. Voorhuis M, Onland-Moret NC, Fauser BC, Ploos van Amstel HK, van der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod 2013;28:496-501
32. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Sha M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-412
33. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 2006;14:253-255